Copyright
©The Author(s) 2023.
World J Diabetes. May 15, 2023; 14(5): 560-564
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.560
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.560
Table 1 Table summarizing the key information of coronavirus disease-19 vaccine related diabetic ketoacidosis in recipients with background type 1 and type 2 diabetes mellitus
| Characteristics | Cases with background type 1 diabetes mellitus | Cases with background type 2 diabetes mellitus |
| Sex | Usually male | Usually male |
| Age group | Adolescent | Elderly |
| Background diabetes control | Poor control | No significant relationship |
| During of diabetic illness | Long | No significant relationship |
- Citation: Joob B, Wiwanitkit V. COVID-19 vaccination and diabetic ketoacidosis. World J Diabetes 2023; 14(5): 560-564
- URL: https://www.wjgnet.com/1948-9358/full/v14/i5/560.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i5.560